| Name | Recombinant Human LRFN5 Fc Chimera Protein, CF |
|---|---|
| Supplier | R&D Systems |
| Catalog | 9385-SA |
| Category | Protein |
| Prices | $329.00 |
| Sizes | 50 µg |
| Species Reactivities | Human |
| Nature | Recombinant |
| Source | Human embryonic kidney cell, HEK293-derived Human LRFN5 (Gln18-Gly527) Accession # Q96NI6 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus |
| Purity | >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. |
| Bioactivity | Measured by its binding ability in a functional ELISA. When Recombinant Human LRFN5 Fc Chimera is used at 1 μg/mL, the concentration of Recombinant Human LAR that produces 50% optimal binding response is 0.15-0.9 μg/mL. |
| Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
| SwissProt/Accession | Q96NI6 |
| Gene | LRFN5 |
| Sequence | No results obtained. Gln18 inferred from enzymatic pyroglutamate treatment revealing Ile19 |
| Supplier Page | Shop |